Elizabeth E. Evans - 21 Mar 2024 Form 4/A Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Operating Officer
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Elizabeth E. Evans
Issuer symbol
VCNX
Transactions as of
21 Mar 2024
Transactions value $
$0
Form type
4/A
Filing time
14 May 2024, 16:35:16 UTC
Date Of Original Report
22 Mar 2024
Previous filing
22 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +1.34K $0.00 1.34K 21 Mar 2024 Common Stock 1.34K $8.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date.